HeartSciences (HSCS) Operating Income Growth (3y) (2024 - 2026)

HeartSciences (HSCS) Operating Income Growth (3y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Abbott Laboratories 184.10 Bn 176.81 Bn 6.27 Bn -3.76%
2 Stryker 128.79 Bn 125.91 Bn 3.81 Bn 8.39%
3 Medtronic 108.97 Bn 99.75 Bn 6.41 Bn 6.17%
4 Boston Scientific 68.57 Bn 67.12 Bn 3.61 Bn 25.88%
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn 7.13%
6 GE HealthCare Technologies 28.40 Bn 26.11 Bn 1.98 Bn -2.70%
7 Dexcom 28.32 Bn 27.20 Bn 750.30 Mn 75.54%
8 Smith & Nephew 26.94 Bn 26.36 Bn - -
9 Koninklijke Philips 25.45 Bn 22.33 Bn 2.07 Bn 34.83%
10 HeartSciences 6.20 Mn 4.50 Mn - -16.63%

Historic Data

Download Data
DateValue
Apr 30, 2026 -16.63%
Oct 31, 2025 -5.32%
Jul 31, 2025 -9.43%
Apr 30, 2025 0.98%
Jan 31, 2025 -29.17%
Oct 31, 2024 -27.54%
Jul 31, 2024 -45.46%